IS4947A - Tróvafloxasín mesýlat tafla - Google Patents

Tróvafloxasín mesýlat tafla

Info

Publication number
IS4947A
IS4947A IS4947A IS4947A IS4947A IS 4947 A IS4947 A IS 4947A IS 4947 A IS4947 A IS 4947A IS 4947 A IS4947 A IS 4947A IS 4947 A IS4947 A IS 4947A
Authority
IS
Iceland
Prior art keywords
troafloxacin
mesylate tablet
mesylate
tablet
troafloxacin mesylate
Prior art date
Application number
IS4947A
Other languages
English (en)
Inventor
Dale Johnson Alton
Michael Sinko Christopher
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of IS4947A publication Critical patent/IS4947A/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IS4947A 1998-01-21 1999-01-19 Tróvafloxasín mesýlat tafla IS4947A (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7201398P 1998-01-21 1998-01-21

Publications (1)

Publication Number Publication Date
IS4947A true IS4947A (is) 1999-07-22

Family

ID=22105016

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4947A IS4947A (is) 1998-01-21 1999-01-19 Tróvafloxasín mesýlat tafla

Country Status (34)

Country Link
US (1) US6187341B1 (is)
EP (1) EP0930068A3 (is)
JP (1) JPH11269072A (is)
KR (1) KR100314977B1 (is)
CN (1) CN1227743A (is)
AP (1) AP1094A (is)
AR (1) AR012780A1 (is)
AU (1) AU758381B2 (is)
BG (1) BG103106A (is)
BR (1) BR9900116A (is)
CA (1) CA2259698C (is)
CO (1) CO4810225A1 (is)
DZ (1) DZ2712A1 (is)
EA (1) EA003247B1 (is)
GT (1) GT199900004A (is)
HR (1) HRP990023A2 (is)
HU (1) HUP9900154A3 (is)
ID (1) ID23735A (is)
IL (1) IL128051A0 (is)
IS (1) IS4947A (is)
MA (1) MA24747A1 (is)
NO (1) NO990243L (is)
NZ (1) NZ333838A (is)
OA (1) OA10958A (is)
PA (1) PA8466701A1 (is)
PE (1) PE20000169A1 (is)
PL (1) PL330981A1 (is)
SG (1) SG70666A1 (is)
SK (1) SK4299A3 (is)
TN (1) TNSN99007A1 (is)
TR (1) TR199900089A3 (is)
TW (1) TW518224B (is)
YU (1) YU2399A (is)
ZA (1) ZA99393B (is)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9915208A (pt) * 1998-11-10 2001-07-31 Bayer Ag Preparado farmacêutico de moxifloxacina
AU1188601A (en) * 1999-09-20 2001-04-24 Alza Corporation Process for lessening polymorphic conversion of a drug
ECSP003699A (es) * 1999-10-08 2002-04-23 Smithkline Beecham Corp Inhibidores de fab i
FR2808441B1 (fr) * 2000-05-04 2004-06-18 Oreal Utilisation de fibres dans une composition de soin ou de maquillage pour matifier la peau
DE10031043A1 (de) * 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
DE60230934D1 (de) * 2001-04-06 2009-03-05 Affinium Pharm Inc Fab-i-inhibitoren
EP1396263A1 (en) * 2002-08-09 2004-03-10 Warner-Lambert Company Film coating for tablets and caplets
EP1575951B1 (en) 2002-12-06 2014-06-25 Debiopharm International SA Heterocyclic compounds, methods of making them and their use in therapy
CN100415284C (zh) * 2002-12-30 2008-09-03 毛友昌 六味木香片的制备方法
WO2004082586A2 (en) 2003-03-17 2004-09-30 Affinium Pharmaceuticals, Inc. Phamaceutical compositions comprising inhibitors of fab i and further antibiotics
EP1459739B1 (en) * 2003-03-19 2008-01-02 The Jordanian Pharmaceutical Manufacturing Co. Ltd. Non-hygroscopic pharmaceutical compositions containing non-hydrated quinoline carboxylic acids
US8906413B2 (en) * 2003-05-12 2014-12-09 Supernus Pharmaceuticals, Inc. Drug formulations having reduced abuse potential
WO2005009395A2 (en) * 2003-07-23 2005-02-03 L. Perrigo Company Cellulosic fiber containing composition
US8450307B2 (en) 2004-06-04 2013-05-28 Affinium Pharmaceuticals, Inc. Therapeutic agents, and methods of making and using the same
WO2006044805A2 (en) * 2004-10-15 2006-04-27 Supernus Pharmaceuticals, Inc. Less abusable pharmaceutical preparations
CA2632476A1 (en) * 2005-12-05 2007-06-14 Affinium Pharmaceuticals, Inc. Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
EP2687533B1 (en) 2006-07-20 2017-07-19 Debiopharm International SA Acrylamide derivatives as FAB I inhibitors
WO2008098374A1 (en) * 2007-02-16 2008-08-21 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab i inhibitors
KR101720885B1 (ko) 2012-06-19 2017-03-28 데비오팜 인터네셔날 에스 에이 (e)-n-메틸-n-((3-메틸벤조푸란-2-일)메틸)-3-(7-옥소-5,6,7,8-테트라히드로-1,8-나프티리딘-3-일)아크릴아미드의전구약물 유도체
RS61312B1 (sr) 2016-02-26 2021-02-26 Debiopharm Int Sa Lek za lečenje infekcija dijabetskog stopala
MY203711A (en) 2019-02-14 2024-07-15 Debiopharm Int Sa Afabicin formulation, method for making the same and uses thereof
JP7418475B2 (ja) 2019-06-14 2024-01-19 デバイオファーム インターナショナル エス.エー. バイオフィルムが関与する細菌感染症を治療するための医薬及びその使用
EP4580618A2 (en) * 2022-08-30 2025-07-09 Pannex Therapeutics Inc. Pannexin-1 modulators and methods of treating disorders in which pannexin-1 is implicated

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3601566A1 (de) * 1986-01-21 1987-07-23 Bayer Ag Pharmazeutische zubereitungen von ciprofloxacin
US5286754A (en) 1986-01-21 1994-02-15 Bayer Aktiengesellschaft Pharmaceutical formulations of ciprofloxacin
US4957554A (en) 1989-08-16 1990-09-18 Minnesota Mining And Manufacturing Company Dimensionally-controlled ceramics
DE4120646A1 (de) 1991-06-22 1992-12-24 Bayer Ag 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate
PL325170A1 (en) * 1995-08-29 1998-07-06 Pfizer Bipolar forms of throwaflocacin

Also Published As

Publication number Publication date
EP0930068A3 (en) 1999-12-22
TNSN99007A1 (fr) 2005-11-10
CN1227743A (zh) 1999-09-08
HRP990023A2 (en) 1999-08-31
DZ2712A1 (fr) 2003-09-01
HUP9900154A2 (hu) 1999-09-28
EP0930068A2 (en) 1999-07-21
NO990243L (no) 1999-07-22
KR19990068014A (ko) 1999-08-25
KR100314977B1 (ko) 2001-11-24
SK4299A3 (en) 2000-06-12
EA199900046A2 (ru) 1999-08-26
CO4810225A1 (es) 1999-06-30
AR012780A1 (es) 2000-11-08
AP9901443A0 (en) 1999-03-31
SG70666A1 (en) 2000-02-22
AU1217399A (en) 1999-08-12
US6187341B1 (en) 2001-02-13
BR9900116A (pt) 2000-05-02
NZ333838A (en) 2000-03-27
EA199900046A3 (ru) 1999-12-29
CA2259698A1 (en) 1999-07-21
TR199900089A2 (xx) 1999-10-21
GT199900004A (es) 2000-07-08
PE20000169A1 (es) 2000-03-10
NO990243D0 (no) 1999-01-20
JPH11269072A (ja) 1999-10-05
PL330981A1 (en) 1999-08-02
HUP9900154A3 (en) 2000-12-28
TW518224B (en) 2003-01-21
ZA99393B (en) 2000-07-21
AP1094A (en) 2002-08-19
MA24747A1 (fr) 1999-10-01
EA003247B1 (ru) 2003-02-27
ID23735A (id) 2000-05-11
OA10958A (en) 2001-10-31
AU758381B2 (en) 2003-03-20
IL128051A0 (en) 1999-11-30
HU9900154D0 (en) 1999-03-29
BG103106A (en) 1999-08-31
PA8466701A1 (es) 2000-09-29
CA2259698C (en) 2003-04-15
TR199900089A3 (tr) 1999-10-21
YU2399A (sh) 2002-06-19

Similar Documents

Publication Publication Date Title
IS4947A (is) Tróvafloxasín mesýlat tafla
ID29066A (id) Turunan fenilglisina
ID27423A (id) Turunan kuinolin
DE69937850D1 (de) Hautablationslaser
ATE341990T1 (de) Sigmidoskop
IS5869A (is) Hraðlosandi tafla
DE59902874D1 (de) Buchsenkontakt
DE59901560D1 (de) Retrograder tibianagel
NO990113D0 (no) Flerskrog-fart°y
ID23234A (id) Turunan-turunan benzosulfona
ID29089A (id) Sediaan farmasi moksifloksasin
ID27484A (id) Turunan adenosina
ID27547A (id) Turunan kuinolin
DE59906931D1 (de) Exzenterzahnradgetriebe
ATE262513T1 (de) Benzoylpyridazine
DE59903966D1 (de) Exzenterzahnradgetriebe
DE60044181D1 (de) Gleitvorrichtung
DE59903106D1 (de) Tripode-gleichlaufdrehgelenk
EP1074250A4 (en) SUGAR-COATED TABLETS
DE59901046D1 (de) Methylcyclotetradec-5-en-1-one
DE59807217D1 (de) Nadellager
DE59808995D1 (de) Endomikroskopsystem
ID28356A (id) Turunam tiazola
DE19842103B4 (de) Stanznietzuführung
NO980087L (no) Klammer